We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 (HEPVACHIV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00451984
Recruitment Status : Unknown
Verified October 2007 by Aalborg Universitetshospital.
Recruitment status was:  Recruiting
First Posted : March 26, 2007
Last Update Posted : November 1, 2007
Information provided by:

March 23, 2007
March 26, 2007
November 1, 2007
March 2007
Not Provided
Antibody response to hepatitis A and hepatitis B
Same as current
Complete list of historical versions of study NCT00451984 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Not Provided
The response to vaccination for hepatitis is reduced in patients with HIV infection. The hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the time of vaccination improves the response rate.
Not Provided
Phase 3
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
  • HIV Infections
  • Hepatitis A
  • Hepatitis B
  • Biological: Twinrix
  • Biological: interleukin-2
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
Not Provided
Not Provided

Inclusion Criteria:

  • Adults with stable antiretroviral therapy and negative for hepatitis A or B

Exclusion Criteria:

  • Prior hepatitis A or B
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Aalborg Universitetshospital
Not Provided
Study Chair: Henrik Nielsen, MD, DMSci Aalborg Hospital, DK-9000 Aalborg, Denmark
Aalborg Universitetshospital
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP